Yervoy

Alligator's concentrated efforts will bear fruit

In Alligator Bioscience's Q3 report, the motive for the company's focus on ATOR-1017 and mitazalimab is reinforced by the former candidate's...

Ultimovac's path towards a universal cancer vaccine

Cancers represent a heavy burden on society and...

Steady progress for Immunicum's ilixadencel over the past year

Immunicum boasts an interesting pipeline containing...

Keytruda takes leadership position in kidney cancer

In 2019, there will be around 73,820 new cases of...

Chinese BeiGene in deal worth up to 270 million USD

Privately owned BioAtla LLC has entered into an agreement with...

Alligator's ATOR-1015 – three Nobel Prizes in one molecule

»Can we show that our concept holds up...